The authors concluded that clinical FSHD is epigenetically distinct from healthy controls; however, DNA methylation does not distinguish all individuals with an FSHD D4Z4 contraction from those without and does not distinguish FSHD1 from FSHD2. The gene discussed is SMCHD1; the disease is facioscapulohumeral muscular dystrophy.